Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

BACKGROUND: The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections. Clinicians often continue vancomycin started empirically even when meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweizer, Marin L, Furuno, Jon P, Harris, Anthony D, Johnson, J Kristie, Shardell, Michelle D, McGregor, Jessina C, Thom, Kerri A, Cosgrove, Sara E, Sakoulas, George, Perencevich, Eli N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206863/
https://www.ncbi.nlm.nih.gov/pubmed/22011388
http://dx.doi.org/10.1186/1471-2334-11-279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206863/
https://www.ncbi.nlm.nih.gov/pubmed/22011388
http://dx.doi.org/10.1186/1471-2334-11-279

Ejemplares similares